UPDATE: Qiagen Anticipates 30 Percent Revenue Growth in 02; Lines Up New Launches | GenomeWeb

NEW YORK, Jan. 24 - Qiagen said on Thursday that it expects total revenue in 2002 to grow 30 percent to $345 million as it prepares a host of new products to launch and begins to streamline its operations in four countries.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.